166 related articles for article (PubMed ID: 3278814)
1. Bacterial cysteine conjugate beta-lyase and the metabolism of cysteine S-conjugates: structural requirements for the cleavage of S-conjugates and the formation of reactive intermediates.
Vamvakas S; Berthold K; Dekant W; Henschler D
Chem Biol Interact; 1988; 65(1):59-71. PubMed ID: 3278814
[TBL] [Abstract][Full Text] [Related]
2. Bacterial beta-lyase mediated cleavage and mutagenicity of cysteine conjugates derived from the nephrocarcinogenic alkenes trichloroethylene, tetrachloroethylene and hexachlorobutadiene.
Dekant W; Vamvakas S; Berthold K; Schmidt S; Wild D; Henschler D
Chem Biol Interact; 1986 Oct; 60(1):31-45. PubMed ID: 3536138
[TBL] [Abstract][Full Text] [Related]
3. Mutagenicity of amino acid and glutathione S-conjugates in the Ames test.
Vamvakas S; Elfarra AA; Dekant W; Henschler D; Anders MW
Mutat Res; 1988 Sep; 206(1):83-90. PubMed ID: 2901035
[TBL] [Abstract][Full Text] [Related]
4. Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2,2-trichlorovinyl)-L-cysteine formed by cysteine conjugate beta-lyase.
Dekant W; Berthold K; Vamvakas S; Henschler D; Anders MW
Chem Res Toxicol; 1988; 1(3):175-8. PubMed ID: 2979728
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic transformation of mercapturic acids derived from halogenated alkenes to reactive and mutagenic intermediates.
Vamvakas S; Dekant W; Berthold K; Schmidt S; Wild D; Henschler D
Biochem Pharmacol; 1987 Sep; 36(17):2741-8. PubMed ID: 3307787
[TBL] [Abstract][Full Text] [Related]
6. Cysteine conjugate beta-lyase-catalyzed bioactivation of bromine-containing cysteine S-conjugates: stoichiometry and formation of 2,2-difluoro-3-halothiiranes.
Finkelstein MB; Dekant W; Anders MW
Chem Res Toxicol; 1996; 9(1):227-31. PubMed ID: 8924595
[TBL] [Abstract][Full Text] [Related]
7. Mutagenicity of hexachloro-1,3-butadiene and its S-conjugates in the Ames test--role of activation by the mercapturic acid pathway in its nephrocarcinogenicity.
Vamvakas S; Kordowich FJ; Dekant W; Neudecker T; Henschler D
Carcinogenesis; 1988 Jun; 9(6):907-10. PubMed ID: 3286031
[TBL] [Abstract][Full Text] [Related]
8. Bioactivation of cysteine conjugates of 1-nitropyrene oxides by cysteine conjugate beta-lyase purified from Peptostreptococcus magnus.
Kataoka K; Kinouchi T; Akimoto S; Ohnishi Y
Appl Environ Microbiol; 1995 Nov; 61(11):3781-7. PubMed ID: 8526486
[TBL] [Abstract][Full Text] [Related]
9. Mutagenicity of the cysteine S-conjugate sulfoxides of trichloroethylene and tetrachloroethylene in the Ames test.
Irving RM; Elfarra AA
Toxicology; 2013 Apr; 306():157-61. PubMed ID: 23416178
[TBL] [Abstract][Full Text] [Related]
10. The role of glutathione conjugate metabolism and cysteine conjugate beta-lyase in the mechanism of S-cysteine conjugate toxicity in LLC-PK1 cells.
Stevens J; Hayden P; Taylor G
J Biol Chem; 1986 Mar; 261(7):3325-32. PubMed ID: 3753976
[TBL] [Abstract][Full Text] [Related]
11. Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.
Lash LH; Sausen PJ; Duescher RJ; Cooley AJ; Elfarra AA
J Pharmacol Exp Ther; 1994 Apr; 269(1):374-83. PubMed ID: 8169843
[TBL] [Abstract][Full Text] [Related]
12. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product compound A in human, nonhuman primate, and rat kidney cytosol and mitochondria.
Iyer RA; Anders MW
Anesthesiology; 1996 Dec; 85(6):1454-61. PubMed ID: 8968194
[TBL] [Abstract][Full Text] [Related]
13. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A).
Iyer RA; Anders MW
Chem Res Toxicol; 1997 Jul; 10(7):811-9. PubMed ID: 9250416
[TBL] [Abstract][Full Text] [Related]
14. Bioactivation of S-(2,2-dihalo-1,1-difluoroethyl)-L-cysteines and S-(trihalovinyl)-L-cysteines by cysteine S-conjugate beta-lyase: indications for formation of both thionoacylating species and thiiranes as reactive intermediates.
Commandeur JN; King LJ; Koymans L; Vermeulen NP
Chem Res Toxicol; 1996; 9(7):1092-102. PubMed ID: 8902263
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of multiple pathways for the metabolism of nephrotoxic cysteine conjugates using selective inhibitors of L-alpha-hydroxy acid oxidase (L-amino acid oxidase) and cysteine conjugate beta-lyase.
Stevens JL; Hatzinger PB; Hayden PJ
Drug Metab Dispos; 1989; 17(3):297-303. PubMed ID: 2568912
[TBL] [Abstract][Full Text] [Related]
16. Structure-mutagenicity and structure-cytotoxicity studies on bromine-containing cysteine S-conjugates and related compounds.
Finkelstein MB; Vamvakas S; Bittner D; Anders MW
Chem Res Toxicol; 1994; 7(2):157-63. PubMed ID: 8199303
[TBL] [Abstract][Full Text] [Related]
17. Human mitochondrial and cytosolic branched-chain aminotransferases are cysteine S-conjugate beta-lyases, but turnover leads to inactivation.
Cooper AJ; Bruschi SA; Conway M; Hutson SM
Biochem Pharmacol; 2003 Jan; 65(2):181-92. PubMed ID: 12504794
[TBL] [Abstract][Full Text] [Related]
18. Assessment of unscheduled DNA synthesis in a cultured line of renal epithelial cells exposed to cysteine S-conjugates of haloalkenes and haloalkanes.
Vamvakas S; Dekant W; Henschler D
Mutat Res; 1989 Apr; 222(4):329-35. PubMed ID: 2704384
[TBL] [Abstract][Full Text] [Related]
19. Renal cysteine conjugate beta-lyase. Bioactivation of nephrotoxic cysteine S-conjugates in mitochondrial outer membrane.
Lash LH; Elfarra AA; Anders MW
J Biol Chem; 1986 May; 261(13):5930-5. PubMed ID: 3700378
[TBL] [Abstract][Full Text] [Related]
20. Thioacylating agents as ultimate intermediates in the beta-lyase catalysed metabolism of S-(pentachloro-butadienyl)-L-cysteine.
Dekant W; Berthold K; Vamvakas S; Henschler D
Chem Biol Interact; 1988; 67(1-2):139-48. PubMed ID: 3168080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
